Top Tweets for #KEYNOTE826
*ASCO episode 4* Gynecologic cancers
Ovarian Cancer is reliant on platinum chemotherapy. This year #ASCO23 showed us an exciting future, and we discuss why:
#MIRASOL
#Oval
#DUOO
#Keynote826
@ASCO @OvarianCancerOz @kinghorncancer #MedTwitter
https://t.co/ubL4PCXhBB
New! #ASCO23 study summary for patients: Adding pembrolizumab to chemo helps people with advanced #CervicalCancer live longer, with or without tumor #PD1 expression
https://t.co/IbBSyy4A6k
#KEYNOTE826 #GYNCSM #ImmunoOnc
Subgroup analyses of all subgroups in #KEYNOTE826 showed improvement in outcomes for recurrent or metastatic #cervicalcancer. 🎉#gyncsm #asco22 https://t.co/H6olKh4WOu
ICYMI: @ASCO rapid ⚡ recommendation update: Clinicians may offer upfront #pembrolizumab and #chemotherapy +/- bevacizumab to eligible pts with persistent, recurrent, or #metastatic #CervicalCarcinoma based on the #KEYNOTE826. https://t.co/w2hzo07XLO #JCOGO #gyncsm
Pembro is not statistically better, but numerically better on PROs for metastatic/recurrent cervical cancer. #keynote826 #SGOMtg #cervixcancer
🚨FDA approves pembro + chemo with/without bevacizumab in 1L for #CervicalCancer based on the results from #KEYNOTE826 presented at #ESMO21
Check out our video w/ Nicoletta Colombo (@IEOufficiale) for more info ⬇️
👉https://t.co/27htkvPOrh👈
@OncoAlert @myESMO #Gynsm
TONIGHT 🗓 October 6, ⏰7 PM ET: @BrownUCancer #bcsm #gycsm Journal Club on @TwitterSpaces.
Join us as we discuss #GIM4 - extended adjuvant endocrine therapy AND #KEYNOTE826 - pembrolizumab for recurrent cervical cancer
📕https://t.co/klJUj8d2nr
📗https://t.co/u4H4bejo2r
Presidential Symposium: KEYNOTE-826 Bradley Monk, MD @ArizonaOncology @GOG #ESMO21 #KEYNOTE826 #MetastaticCervicalCancer #Cancer #Research
https://t.co/7a38iDvPVk
#子宮頸がん を対象とした #Keytrruda と化学療法の併用試験 #Keynote826 試験 は、OSとPFSにおいて肯定的な結果が得られ、1LにおけるAvastin併用の有無や患者のPD-L1ステータスに関わらず、すべての面で勝利した。https://t.co/Cqnv6sgbjd
#エバリュエート
📢 clinical trial result alert #keynote826
Platinum-based chemo with immunotherapy #pembro as first line therapy for metastatic #cervicalcancer met it's primary endpoint of OS and PFS 🥳
Looking forward to more trial results & details 🤓
JUST IN: Phase 3 KEYNOTE-826 trial of pembrolizumab in combination with platinum-based chemotherapy (paclitaxel+cisplatin/carboplatin) +/- bevacizumab, met its primary endpoints of OS & PFS for 1L metastatic cervical cancer @OncoAlert
https://t.co/taMySL0psx
Most Popular Users
Elon Musk 
@elonmusk
241.2M followers
Barack Obama
@barackobama
119.1M followers
Cristiano Ronaldo
@cristiano
112.8M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.3M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.5M followers
KATY PERRY
@katyperry
89M followers
Taylor Swift
@taylorswift13
82.9M followers
Lady Gaga
@ladygaga
74.4M followers
Virat Kohli
@imvkohli
71.9M followers
Kim Kardashian
@kimkardashian
70.4M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
64.8M followers
Bill Gates
@billgates
64.6M followers
The Ellen Show
@theellenshow
62.4M followers
Selena Gomez
@selenagomez
62.1M followers
CNN
@cnn
61.8M followers
X
@x
60.8M followers